官方服务:
资源简介:
Clinical Study Reports on Orlistat released by EMA
应用场景:
创建时间:
2016-06-09
相关数据集
Study of Ruxolitinib in Colorectal Cancer Patients
The purpose of this study was to determine if ruxolitinib, in combination with regorafenib, is safe and effective in the treatment of metastatic colorectal cancer.
NIAID Data Ecosystem120
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
The purpose of this study is to assess the safety and clinical efficacy of ibrutinib in subjects with steroid dependent or refractory Chronic Graft Versus Host Disease.
DataCite Commons2024-12-04 更新80
MOESM4 of Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study
Additional file 4. Trial organization.
DataCite Commons2024-12-17 更新70
虎力散胶囊治疗膝骨关节炎临床与药效试验数据分析平台
平台数据由 6 张互相关联的 CSV 文件组成:1. patients.csv — 患者基本信息表,以受试者编号(格式:HLS-T001~HLS-T035 为治疗组,HLS-C001~HLS-C035 为对照组)作为主键跨表关联,记录每位受试者的人口学特征、基线评分和入组状态;2. efficacy.csv — 临床疗效数据表,记录四个随访时间点(基线、第2周、第4周、随访期)的疗效评分,脱落受试
上海市数据产品知识产权管理平台2026-03-31 更新90
All Adverse Events during the Study Period in the High-Gonadotropin Cetrorelix and Placebo Groups.
* There were no significant between-group differences.All Adverse Events during the Study Period in the High-Gonadotropin Cetrorelix and Placebo Groups.
Figshare2015-12-03 更新70



